Disturbed
homocysteine metabolism may contribute to amyloidogenesis by modulating the
amyloid precursor
protein (APP) production and processing. The objective of this study was to investigate the relationships between cerebral
amyloid production and both blood and cerebrospinal fluid (CSF) markers of the
homocysteine metabolism. We assessed CSF concentrations of soluble APPα, soluble APPβ, and
amyloid β1-42 (Aβ1-42), as well as plasma levels of
homocysteine (Hcys), total
vitamin B12, and
folate, and CSF concentrations of
homocysteine (Hcys-CSF),
5-methyltetrahydrofolate (5-MTHF),
S-adenosylmethionine (SAM), and
S-adenosylhomocysteine (SAH) in 59 subjects with normal cognition. Linear regression analyses were performed to assess associations between
homocysteine metabolism parameters and
amyloid production. The study was approved by the Ethical Committee of the University of Bonn. After controlling for age, gender, APOEe4 status, and
albumin ratio (Qalb), higher Aβ1-42 CSF levels were associated with high Hcys and low
vitamin B12 plasma levels as well as with high Hcys, high SAH, and low 5-MTHF CSF levels. Higher CSF concentrations of sAPPα and sAPPβ were associated with high SAH levels. The results suggest that disturbed
homocysteine metabolism is related to increased CSF levels of sAPP forms and Aβ1-42, and may contribute to the accumulation of
amyloid pathology in the brain. Disturbed
homocysteine metabolism may contribute to amyloidogenesis by modulating the
amyloid precursor
protein (APP) production and processing. We found associations between CSF levels of soluble APP forms and Aβ1-42, and markers of the
homocysteine metabolism in both plasma and CSF in adults with normal cognition. Disturbed
homocysteine metabolism may represent a target for preventive and early disease-modifying interventions in
Alzheimer's disease.